Gene · 5550
Papers2,494
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,494
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arbuscular mycorrhizal fungi trigger danger-associated peptide signaling and inhibit carbon-phosphorus exchange with nonhost plants. | Plant Cell Environ | 2023 | 37151160 | PubTator, text mining | PubMed |
| Safety of equine tetanus antitoxin for prophylactic use in Ethiopia: a retrospective multi-center study. | Trop Med Health | 2023 | 37147727 | PubTator, text mining | PubMed |
| Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin? | Eur J Intern Med | 2023 | 37130772 | PubTator, text mining | PubMed |
| The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer. | Front Endocrinol (Lausanne) | 2023 | 37124730 | PubTator, text mining | PubMed |
| An integrated signature of extracellular matrix proteins and a diastolic function imaging parameter predicts post-MI long-term outcomes. | Front Cardiovasc Med | 2023 | 37123479 | PubTator, text mining | PubMed |
| Aberrant methylation of dipeptidyl peptidase‑like 6 as a potential prognostic biomarker for lung adenocarcinoma. | Oncol Lett | 2023 | 37123021 | PubTator, text mining | PubMed |
| Development and validation of a risk score for predicting inconsistent condom use with women among men who have sex with men and women. | BMC Public Health | 2023 | 37085861 | PubTator, text mining | PubMed |
| Use of a multi-gene pharmacogenetic panel reduces adverse drug effects. | Cell Rep Med | 2023 | 37084734 | PubTator, text mining | PubMed |
| Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial. | Chin Med | 2023 | 37069570 | PubTator, text mining | PubMed |
| Utilization of mental health services in relation to the intention to reduce chemsex behavior among clients from an integrated sexual health services center in Taiwan. | Harm Reduct J | 2023 | 37062840 | PubTator, text mining | PubMed |
| Iridium(III) polypyridine artificial metalloenzymes with tunable photophysical properties: a new platform for visible light photocatalysis in aqueous solution. | Dalton Trans | 2023 | 37060130 | PubTator, text mining | PubMed |
| Theoretical investigation of electrochromic mechanism in D-A conjugated polymers in visible and infrared bands. | RSC Adv | 2023 | 37057261 | PubTator, text mining | PubMed |
| Effects of 2 modes of positive pressure ventilation on respiratory mechanics and gas exchange in foals. | J Vet Intern Med | 2023 | 37051768 | PubTator, text mining | PubMed |
| COVID-19 and Diarylamidines: The Parasitic Connection. | Int J Mol Sci | 2023 | 37047556 | PubTator, text mining | PubMed |
| Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors. | Int J Mol Sci | 2023 | 37047270 | PubTator, text mining | PubMed |
| Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia. | Int J Mol Sci | 2023 | 37046989 | PubTator, text mining | PubMed |
| Characterization of genome-wide STR variation in 6487 human genomes. | Nat Commun | 2023 | 37045857 | PubTator, text mining | PubMed |
| A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy. | Sci Transl Med | 2023 | 37043557 | PubTator, text mining | PubMed |
| Altered ureido protein modification profiles in seminal plasma extracellular vesicles of non-normozoospermic men. | Front Endocrinol (Lausanne) | 2023 | 37033249 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5550/papers?page=14